AIG Completes Sale Of Tokyo Real Estate Asset To Nippon Life Insurance Company
NEW YORK -- May 28, 2009 -- American International Group, Inc. (AIG) announced today that it has completed the sale of its prime real estate holding in the Otemachi District in Tokyo to Nippon Life Insurance Company.
Under the terms of the agreement, Nippon Life Insurance Company paid approximately $1.2 billion in cash (¥115,500mm) for the entire building and the approximately one acre of land on which it is situated.
“We are pleased to complete the sale in less than 30 days after reaching an agreement on this transaction,” said Edward Liddy, AIG’s Chairman and Chief Executive Officer. “Despite a very challenging global real estate environment, AIG was able to realize an attractive price for this prized property. The sale of this asset represents another step forward in AIG’s asset disposition and restructuring efforts and should serve the best interests of AIG and its constituents.”
Source: American International Group, Inc.
Scroll down for related articles:
Related articles
- 2009-05-29: AIG Completes Sale Of Tokyo Real Estate Asset To Nippon Life Insurance Company
- 2009-05-12: AIG Announces $1.2 Billion Sale Of Tokyo Real Estate Asset To Nippon Life Insurance Company
- 2009-05-19: AIG: AIA Group to Seek Public Listing in Asia
- 2009-10-13: AIG Enters into Agreement to Sell Nan Shan to Consortium Led by Primus Financial
- 2009-06-03: AIG To Sell Its Argentina-Based Consumer Finance Operations
- 2009-06-22: AIG Extends Exchange Offers
- 2009-06-11: AIG Closes Secondary Offering Of Transatlantic Holdings, Inc. Shares
- 2009-06-08: AIG Announces Exercise of Underwriter's Option in Its Secondary Offering of Shares in Transatlantic Holdings, Inc.
- 2009-06-05: AIG Prices Secondary Offering Of Its Transatlantic Holdings, Inc. Shares
- 2009-06-03: Toyota Plans to Lease Plug-in Hybrid Vehicles in Japan
- 2009-05-29: AIG Announces Secondary Offering Of Its Shares In Transatlantic Holdings, Inc. (TRH)
- 2009-05-27: Novartis To Enter Japan Vaccines Market Through Agreement For Haemophilus Influenzae Type B (Hib) Vaccine